Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Venous thromboembolism prophylaxis].

B Dohmen1, W Gogarten, R Kuhlen

  • 1Klinik für Anästhesiologie, Aachen, Germany. bdohmen@ukaachen.de

Der Anaesthesist
|August 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Telemedical anesthesia consent - Are the patients ready for it? : A comparative requirement analysis before and during the pandemic].

Die Anaesthesiologie·2024
Same author

Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol: a multicentre randomised controlled trial.

Anaesthesia·2024
Same author

[Resuscitation of children with persistent ventricular fibrillation-A case for a mechanical resuscitation device?]

Die Anaesthesiologie·2023
Same author

Burden of hospital-acquired SARS-CoV-2 infections in Germany: occurrence and outcomes of different variants.

The Journal of hospital infection·2022
Same author

[When emergency physician and tele-emergency physician save life together : A case description on the application of prehospital telemedicine for ventricular tachycardia with hemodynamic instability].

Der Anaesthesist·2021
Same author

[Appropriate allocation of resources for interhospital transfer in emergency medical service-is a physician in the dispatch center helpful?]

Der Anaesthesist·2020
Same journal

[Promoting young academics in anesthesiology: factors for an attractive internship].

Der Anaesthesist·2022
Same journal

[Respiratory support in COVID-19: all in due time!]

Der Anaesthesist·2022
Same journal

[Noninvasive respiratory support and invasive ventilation in COVID‑19 : Where do we stand today?]

Der Anaesthesist·2022
Same journal

[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine].

Der Anaesthesist·2022
Same journal

[Anesthesia in patients with acute porphyria].

Der Anaesthesist·2022
Same journal

[Quality and safe anesthesia for all children : That is their right!]

Der Anaesthesist·2022
See all related articles

Hospitalized patients frequently develop venous thromboembolism (VTE), a condition that increases mortality. Pharmacological prophylaxis is essential for patients with intermediate or high VTE risk.

Area of Science:

  • Internal Medicine
  • Cardiology
  • Vascular Medicine

Context:

  • Venous thromboembolism (VTE) is a prevalent complication in hospitalized individuals.
  • VTE encompasses both subclinical events and symptomatic deep vein thrombosis or pulmonary embolism.
  • VTE significantly contributes to in-hospital morbidity and mortality.

Purpose:

  • To highlight the significance of venous thromboembolism in hospitalized patients.
  • To underscore the role of risk factors in VTE development.
  • To emphasize the necessity of pharmacological prophylaxis in high-risk patients.

Summary:

  • Venous thromboembolism (VTE) is a common complication in hospitalized patients, leading to significant morbidity and mortality.
  • Risk factors, both dispositional and expositional, exacerbate the likelihood of VTE.

Related Experiment Videos

  • Pharmacological thromboembolism prophylaxis is mandatory for patients identified as intermediate or high risk.

    • Impact:

    • Increased awareness of VTE as a critical in-hospital complication.
    • Reinforces the importance of risk assessment for VTE.
    • Guides clinical practice towards mandatory pharmacological prophylaxis in at-risk populations.